Illumina (ILMN) Receivables - Other (2021 - 2022)

Illumina (ILMN) posted quarterly Receivables - Other of $16.0 million for Q1 2022, up 14.29% year-over-year from $14.0 million in Q1 2021, and up 14.29% on a QoQ basis from $14.0 million in Q1 2021.

Illumina (ILMN) Receivables - Other (2021 - 2022) Analysis & Trends

Illumina has reported Receivables - Other for 2 years, with the latest figure at $16.0 million in Q1 2022.

  • Receivables - Other for Q1 2022 came in at $16.0 million, up 14.29% year-over-year; the trailing twelve-month figure through Jan 2022 was $16.0 million (up 14.29% YoY), and the FY2022 annual result was $16.0 million, up 14.29% from the prior year.
  • Receivables - Other climbed to $16.0 million in Q1 2022, from $14.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $16.0 million in Q1 2022 and troughed at $14.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.92 Bn 209.86 Bn 8.34 Bn
2 Danaher 140.37 Bn 136.02 Bn 3.61 Bn
3 Idexx Laboratories 46.17 Bn 45.97 Bn 779.09 Mn
4 Agilent Technologies 39.76 Bn 37.96 Bn 990.00 Mn
5 Iqvia Holdings 39.41 Bn 37.33 Bn 1.44 Bn
6 Natera 38.75 Bn 37.65 Bn 696.04 Mn
7 Illumina 30.07 Bn 28.90 Bn 770.00 Mn
8 Mettler Toledo International 28.62 Bn 28.56 Bn 650.22 Mn
9 Quest Diagnostics 26.15 Bn 25.53 Bn 1.03 Bn
10 Labcorp Holdings 25.87 Bn 24.89 Bn 1.01 Bn

Historic Data

Download Data
DateValue
Jan 2, 2022 16.00 Mn
Jan 2, 2022 16.00 Mn
Jan 3, 2021 14.00 Mn
Jan 3, 2021 14.00 Mn